BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10968706)

  • 1. Immunohistochemistry in the diagnosis of neoplasms of the central nervous system.
    Morrison CD; Prayson RA
    Semin Diagn Pathol; 2000 Aug; 17(3):204-15. PubMed ID: 10968706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.
    Ikota H; Kinjo S; Yokoo H; Nakazato Y
    Acta Neuropathol; 2006 May; 111(5):475-82. PubMed ID: 16598485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of nervous system antigens: diagnostic applications in surgical neuropathology.
    Clark HB
    Semin Diagn Pathol; 1984 Nov; 1(4):309-16. PubMed ID: 6443793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
    Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
    Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors.
    Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA
    Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential immunohistochemical diagnosis of tumors of the human central nervous system using monoclonal antibodies].
    Vial'tseva IuIu; Bukhvalov IB; Vasilov RG
    Arkh Patol; 1996; 58(2):28-32. PubMed ID: 8712936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis-related histomorphological and immunohistochemical markers in central nervous system tumors of childhood and adolescence.
    Rickert CH; Paulus W
    Acta Neuropathol; 2005 Jan; 109(1):69-92. PubMed ID: 15647946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell neoplasms and pseudoneoplastic lesions of the central nervous system.
    Gökden M; Roth KA; Carroll SL; Wick MR; Schmidt RE
    Semin Diagn Pathol; 1997 Nov; 14(4):253-69. PubMed ID: 9383825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistology of neuroendocrine and neuroectodermal tumors.
    Wick MR
    Semin Diagn Pathol; 2000 Aug; 17(3):194-203. PubMed ID: 10968705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein.
    Curran AE; White DK; Damm DD; Murrah VA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):194-9. PubMed ID: 11174597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M; Budka H; Rössler K; Hainfellner JA
    Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of immunohistochemistry to the differential diagnosis of primary and metastatic neoplasma of the central nervous system (CNS).
    Markaki S; Prevedorou D; Georgoulakis G; Bouja J; Karabela-Bouropoulou V
    Arch Anat Cytol Pathol; 1989; 37(3):93-8. PubMed ID: 2751365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of immunohistochemical techniques in intramedullary Schwann-cell tumours.
    Radhakrishnan VV; Saraswathy A; Radhakrishnan NS; Rout D
    Indian J Pathol Microbiol; 1993 Jan; 36(1):87-91. PubMed ID: 8354567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry of medulloepithelioma and neural tube.
    Khoddami M; Becker LE
    Pediatr Pathol Lab Med; 1997; 17(6):913-25. PubMed ID: 9353831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of metastatic neoplasms of the central nervous system.
    Becher MW; Abel TW; Thompson RC; Weaver KD; Davis LE
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):935-44. PubMed ID: 17021398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of glial fibrillary acidic protein in central nervous tumors using an immunohistochemical method. Preliminary study of 33 cases (author's transl)].
    Pasquier B; Pasquier D; Tanous AM; Lachard A; N'Golet A; Panh MH; Couderc P
    Sem Hop; 1980 Nov 8-15; 56(41-42):1720-1. PubMed ID: 6255599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.